Print Page

Products found to contain undeclared medicines

 
The United States: Public Notification: Body Shape Weight Loss System contains hidden drug ingredient sibutramine
 
The US Food and Drug Administration (FDA) is advising consumers not to purchase or use Body Shape Weight Loss System, a product promoted for weight loss. This product was identified during an examination of imported goods. FDA laboratory analysis confirmed that Body Shape Weight Loss System contains sibutramine. Sibutramine is a controlled substance that was removed from the market in Oct 2010 for safety reasons. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or heart rate in some people and may present a significant risk for people with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.

Please refer to the following website in FDA for details: http://www.fda.gov/drugs/medication-health-fraud/public-notification-body-shape-weight-loss-system-contains-hidden-drug-ingredient-0

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/Wednesday, Nov 25, 2020
Issued at HKT 14:00
 
Related Information:
The United States: Public Notification: Body Shape Weight Loss System contains h... Posted 2024-10-03
The United States: Public Notification: Body Shape Weight Loss System contains h... Posted 2018-07-04
 
back